Information Provided By:
Fly News Breaks for April 30, 2015
VRTX
Apr 30, 2015 | 07:59 EDT
Leerink raised its price target for Vertex to $150 saying it believes the company is best positioned to to establish a dominant franchise in cystic fibrosis. The firm keeps an Outperform rating on the stock following the company's Q1 results.
News For VRTX From the Last 2 Days
There are no results for your query VRTX